Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Third-Party 510(k) Reviews Increasingly Time-Consuming For CDRH – Kahan

This article was originally published in The Gray Sheet

Executive Summary

CDRH is hosting a face-to-face training session for "accredited persons" as part of ongoing efforts to improve its third-party review program

You may also be interested in...



CDRH Persistence Pays Off: Third-Party Review Acceptance Rates On The Rise

FDA device center efforts to reverse a third-party 510(k) review lag are succeeding, Program Coordinator Eric Rechen claimed May 24

CDRH Persistence Pays Off: Third-Party Review Acceptance Rates On The Rise

FDA device center efforts to reverse a third-party 510(k) review lag are succeeding, Program Coordinator Eric Rechen claimed May 24

Expanded MedSun Surveillance Network Highlighted By FDA; Funding Planned

FDA intends to allocate $34 mil. to its Medical Product Surveillance Network (MedSun) in FY 2006, with the goal of recruiting 350 facilities into the program

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel